![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: OAT |
Gene summary for OAT |
![]() |
Gene information | Species | Human | Gene symbol | OAT | Gene ID | 4942 |
Gene name | ornithine aminotransferase | |
Gene Alias | GACR | |
Cytomap | 10q26.13 | |
Gene Type | protein-coding | GO ID | GO:0003008 | UniProtAcc | A0A140VJQ4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4942 | OAT | GSM4909281 | Human | Breast | IDC | 1.47e-10 | 4.64e-01 | 0.21 |
4942 | OAT | GSM4909285 | Human | Breast | IDC | 1.02e-02 | 1.93e-01 | 0.21 |
4942 | OAT | GSM4909286 | Human | Breast | IDC | 3.59e-06 | -2.34e-01 | 0.1081 |
4942 | OAT | GSM4909293 | Human | Breast | IDC | 3.75e-02 | 1.29e-01 | 0.1581 |
4942 | OAT | GSM4909296 | Human | Breast | IDC | 1.20e-11 | -3.46e-01 | 0.1524 |
4942 | OAT | GSM4909297 | Human | Breast | IDC | 6.92e-13 | -1.28e-01 | 0.1517 |
4942 | OAT | GSM4909301 | Human | Breast | IDC | 3.92e-06 | -3.32e-01 | 0.1577 |
4942 | OAT | GSM4909304 | Human | Breast | IDC | 1.60e-03 | -2.78e-01 | 0.1636 |
4942 | OAT | GSM4909307 | Human | Breast | IDC | 3.05e-02 | -2.60e-01 | 0.1569 |
4942 | OAT | GSM4909311 | Human | Breast | IDC | 1.03e-30 | -4.27e-01 | 0.1534 |
4942 | OAT | GSM4909312 | Human | Breast | IDC | 1.01e-10 | -5.33e-02 | 0.1552 |
4942 | OAT | GSM4909315 | Human | Breast | IDC | 1.56e-06 | -3.51e-01 | 0.21 |
4942 | OAT | GSM4909319 | Human | Breast | IDC | 4.08e-38 | -2.95e-01 | 0.1563 |
4942 | OAT | GSM4909320 | Human | Breast | IDC | 8.27e-03 | -4.42e-01 | 0.1575 |
4942 | OAT | GSM4909321 | Human | Breast | IDC | 1.21e-17 | -2.75e-01 | 0.1559 |
4942 | OAT | brca10 | Human | Breast | Precancer | 3.00e-11 | -4.93e-01 | -0.0029 |
4942 | OAT | NCCBC14 | Human | Breast | DCIS | 1.34e-02 | -9.08e-03 | 0.2021 |
4942 | OAT | NCCBC5 | Human | Breast | DCIS | 3.50e-06 | -3.44e-01 | 0.2046 |
4942 | OAT | P1 | Human | Breast | IDC | 2.52e-14 | -2.15e-01 | 0.1527 |
4942 | OAT | DCIS2 | Human | Breast | DCIS | 9.37e-68 | 1.72e-01 | 0.0085 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005123521 | Liver | HCC | maintenance of location | 185/7958 | 327/18723 | 1.70e-07 | 3.12e-06 | 185 |
GO:00550882 | Liver | HCC | lipid homeostasis | 103/7958 | 167/18723 | 4.27e-07 | 7.18e-06 | 103 |
GO:004648611 | Liver | HCC | glycerolipid metabolic process | 215/7958 | 392/18723 | 4.54e-07 | 7.49e-06 | 215 |
GO:004501711 | Liver | HCC | glycerolipid biosynthetic process | 143/7958 | 252/18723 | 3.27e-06 | 4.31e-05 | 143 |
GO:003025821 | Liver | HCC | lipid modification | 123/7958 | 212/18723 | 3.50e-06 | 4.58e-05 | 123 |
GO:00192162 | Liver | HCC | regulation of lipid metabolic process | 181/7958 | 331/18723 | 4.58e-06 | 5.79e-05 | 181 |
GO:00090632 | Liver | HCC | cellular amino acid catabolic process | 70/7958 | 110/18723 | 6.12e-06 | 7.52e-05 | 70 |
GO:00066504 | Liver | HCC | glycerophospholipid metabolic process | 168/7958 | 306/18723 | 7.27e-06 | 8.62e-05 | 168 |
GO:004647411 | Liver | HCC | glycerophospholipid biosynthetic process | 121/7958 | 211/18723 | 9.12e-06 | 1.06e-04 | 121 |
GO:001087621 | Liver | HCC | lipid localization | 228/7958 | 448/18723 | 1.80e-04 | 1.41e-03 | 228 |
GO:005509221 | Liver | HCC | sterol homeostasis | 59/7958 | 97/18723 | 2.06e-04 | 1.58e-03 | 59 |
GO:004263221 | Liver | HCC | cholesterol homeostasis | 58/7958 | 96/18723 | 2.99e-04 | 2.13e-03 | 58 |
GO:00199152 | Liver | HCC | lipid storage | 53/7958 | 87/18723 | 4.01e-04 | 2.71e-03 | 53 |
GO:19016062 | Liver | HCC | alpha-amino acid catabolic process | 53/7958 | 87/18723 | 4.01e-04 | 2.71e-03 | 53 |
GO:00066412 | Liver | HCC | triglyceride metabolic process | 59/7958 | 100/18723 | 6.35e-04 | 3.93e-03 | 59 |
GO:000663911 | Liver | HCC | acylglycerol metabolic process | 72/7958 | 128/18723 | 1.16e-03 | 6.54e-03 | 72 |
GO:0009064 | Liver | HCC | glutamine family amino acid metabolic process | 47/7958 | 78/18723 | 1.17e-03 | 6.54e-03 | 47 |
GO:000663811 | Liver | HCC | neutral lipid metabolic process | 72/7958 | 129/18723 | 1.54e-03 | 8.14e-03 | 72 |
GO:001097511 | Liver | HCC | regulation of neuron projection development | 220/7958 | 445/18723 | 1.68e-03 | 8.78e-03 | 220 |
GO:0009100 | Liver | HCC | glycoprotein metabolic process | 193/7958 | 387/18723 | 1.89e-03 | 9.62e-03 | 193 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa00330 | Colorectum | AD | Arginine and proline metabolism | 23/2092 | 50/8465 | 8.27e-04 | 5.90e-03 | 3.76e-03 | 23 |
hsa003301 | Colorectum | AD | Arginine and proline metabolism | 23/2092 | 50/8465 | 8.27e-04 | 5.90e-03 | 3.76e-03 | 23 |
hsa003302 | Colorectum | SER | Arginine and proline metabolism | 17/1580 | 50/8465 | 7.12e-03 | 3.77e-02 | 2.74e-02 | 17 |
hsa003303 | Colorectum | SER | Arginine and proline metabolism | 17/1580 | 50/8465 | 7.12e-03 | 3.77e-02 | 2.74e-02 | 17 |
hsa003304 | Colorectum | MSS | Arginine and proline metabolism | 23/1875 | 50/8465 | 1.52e-04 | 1.24e-03 | 7.61e-04 | 23 |
hsa003305 | Colorectum | MSS | Arginine and proline metabolism | 23/1875 | 50/8465 | 1.52e-04 | 1.24e-03 | 7.61e-04 | 23 |
hsa0033021 | Liver | HCC | Arginine and proline metabolism | 33/4020 | 50/8465 | 6.28e-03 | 1.77e-02 | 9.83e-03 | 33 |
hsa0033031 | Liver | HCC | Arginine and proline metabolism | 33/4020 | 50/8465 | 6.28e-03 | 1.77e-02 | 9.83e-03 | 33 |
hsa0033010 | Oral cavity | OSCC | Arginine and proline metabolism | 30/3704 | 50/8465 | 1.50e-02 | 3.26e-02 | 1.66e-02 | 30 |
hsa0033013 | Oral cavity | OSCC | Arginine and proline metabolism | 30/3704 | 50/8465 | 1.50e-02 | 3.26e-02 | 1.66e-02 | 30 |
hsa0033023 | Oral cavity | LP | Arginine and proline metabolism | 26/2418 | 50/8465 | 3.94e-04 | 2.08e-03 | 1.34e-03 | 26 |
hsa0033033 | Oral cavity | LP | Arginine and proline metabolism | 26/2418 | 50/8465 | 3.94e-04 | 2.08e-03 | 1.34e-03 | 26 |
hsa003309 | Prostate | BPH | Arginine and proline metabolism | 18/1718 | 50/8465 | 7.17e-03 | 2.32e-02 | 1.43e-02 | 18 |
hsa0033012 | Prostate | BPH | Arginine and proline metabolism | 18/1718 | 50/8465 | 7.17e-03 | 2.32e-02 | 1.43e-02 | 18 |
hsa0033022 | Prostate | Tumor | Arginine and proline metabolism | 19/1791 | 50/8465 | 4.73e-03 | 1.67e-02 | 1.03e-02 | 19 |
hsa0033032 | Prostate | Tumor | Arginine and proline metabolism | 19/1791 | 50/8465 | 4.73e-03 | 1.67e-02 | 1.03e-02 | 19 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
OAT | SNV | Missense_Mutation | novel | c.310C>G | p.Gln104Glu | p.Q104E | P04181 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-E9-A3QA-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
OAT | SNV | Missense_Mutation | novel | c.989N>A | p.Cys330Tyr | p.C330Y | P04181 | protein_coding | deleterious(0) | probably_damaging(0.954) | TCGA-PE-A5DC-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
OAT | insertion | In_Frame_Ins | novel | c.842_843insTTGTTT | p.Glu281delinsAspCysLeu | p.E281delinsDCL | P04181 | protein_coding | TCGA-A8-A09C-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
OAT | deletion | Frame_Shift_Del | novel | c.841delN | p.Glu281LysfsTer7 | p.E281Kfs*7 | P04181 | protein_coding | TCGA-A8-A09C-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
OAT | SNV | Missense_Mutation | rs763064048 | c.1111G>A | p.Val371Ile | p.V371I | P04181 | protein_coding | tolerated(0.11) | benign(0.101) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
OAT | SNV | Missense_Mutation | rs121965054 | c.1180T>C | p.Cys394Arg | p.C394R | P04181 | protein_coding | tolerated(0.06) | benign(0.291) | TCGA-AD-6964-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folfox | PD |
OAT | SNV | Missense_Mutation | rs121965044 | c.1250N>T | p.Pro417Leu | p.P417L | P04181 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AZ-4615-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | xeloda | PD |
OAT | SNV | Missense_Mutation | c.1022N>G | p.Glu341Gly | p.E341G | P04181 | protein_coding | tolerated(0.13) | benign(0.38) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
OAT | SNV | Missense_Mutation | novel | c.965N>T | p.Thr322Ile | p.T322I | P04181 | protein_coding | deleterious(0) | probably_damaging(0.978) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
OAT | SNV | Missense_Mutation | rs1804030 | c.460N>T | p.Arg154Cys | p.R154C | P04181 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
4942 | OAT | ENZYME, DRUGGABLE GENOME | GABACULINE | GABACULINE | 26288681 |
Page: 1 |